- Country: USA
- Summary: Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus
- UST Ref No: 124926595
- Deadline: 27 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: W81K0225QA100
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Medical Readiness Contracting Office - Pacific, Joint Base Lewis McChord Health Contracting Branch is issuing this sources sought notice for informational purposes only. The notice is a means of conducting market research to identify industry-s capabilities.
The Madigan Army Medical Center (MAMC) Department of Pathology requires reagents for the detection of Mycobacterium tuberculosis (TB), a QuantiFERON TB Gold-Plus assay.
This sources sought notice is not a solicitation for quotations, proposals nor invitation for bids. Any information submitted by respondents to this notice is strictly voluntary and will not be compensated. Telephonic inquiries will not be accepted or acknowledged. The Government will not evaluate the information received nor provide comments or feedback.
Your response to the information requested will assist the Government in determining the appropriate acquisition method. Businesses of all sizes are encouraged to respond; however, each respondent must clearly identify their business size in their capabilities and qualifications statement. A determination by the Government not to compete this proposed effort based upon responses to this notice is solely within the discretion of the Government. The Government is not obligated to issue a solicitation nor award a contract under this announcement. If a solicitation is released, it will be synopsized on the Government-Wide Point of Entry (GPE). It is the responsibility of potential offerors to monitor the GPE for additional information pertaining to this requirement.
Project Background
The MAMC Department of Pathology currently uses QuantiFERON TB Gold-Plus assay to detect TB using the LIAISON XL System. Qiagen QFT Gold Plus is a testing method that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB). Qiagen is the only FDA approved source available for in house latent TB testing from blood samples using InterFeron ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINReagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus - USA Tender
The DEPT OF DEFENSE | DEPT OF THE ARMY, a Government sector organization in USA, has announced a new tender for Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus. This tender is published on USARFP under UST Ref No: 124926595 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-27.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
